Literature DB >> 21140103

Development of pituitary apoplexy during TRH/GnRH test in a patient with pituitary macroadenoma.

F Kılıçlı1, H S Dökmetaş, M Gürelik.   

Abstract

Pituitary apoplexy occurs as a very rare complication following pituitary function tests. Signs and symptoms are due to the rapid expansion of an infarcted and/or haemorrhagic pituitary adenoma. We report a case of macroadenoma, in which pituitary apoplexy developed 30 minutes after administration of thyrotropin-releasing hormone (TRH) and gonadotropin-releasing hormone (GnRH) injections. Magnetic resonance (MR) imaging had earlier revealed several haemorrhagic zones. After the TRH and GnRH injections, the patient complained of visual defect. MR imaging demonstrated an increase in the size of the pituitary adenoma and several haemorrhagic zones that formed a fluid-fluid level at the centre of the lesion. The pituitary mass was removed using the transsphenoidal approach. On immunostaining, follicle-stimulating and luteinising hormones were strongly positive, while prolactin was weakly positive. Pituitary functions were evaluated by dynamic function tests at six weeks post operation. The patient's pituitary functions and visual acuity were found to be normal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140103

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  2 in total

1.  Pituitary apoplexy associated with endocrine stimulation test: endocrine stimulation test, treatment, and outcome.

Authors:  Takahiro Yamamoto; Shigetoshi Yano; Jun-Ichiro Kuroda; Yu Hasegawa; Takuichiro Hide; Jun-Ichi Kuratsu
Journal:  Case Rep Endocrinol       Date:  2012-08-15

Review 2.  Multidisciplinary Management of Pituitary Apoplexy.

Authors:  Adriana Albani; Francesco Ferraù; Filippo Flavio Angileri; Felice Esposito; Francesca Granata; Felicia Ferreri; Salvatore Cannavò
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.